Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Immune thrombocytopenia (ITP) World Impact Survey(I-WISh): impact of ITP on health-related quality of life

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Clinically-suspected cast nephropathy: A retrospective, national, real-world study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cerebral Oxygen Metabolism in Adults with Sickle Cell Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Poor Head Growth Is Associated with Later Mental Delay among Vietnamese Preterm Infants: A Follow-up Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The health status of newly arrived asylum-seeking minors in Denmark: a nationwide register-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Health status of refugees newly resettled in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The global COVID-19 response must include refugees and migrants

    Research output: Contribution to journalEditorialpeer-review

  • Nichola Cooper
  • Alexandra Kruse
  • Caroline Kruse
  • Shirley Watson
  • Mervyn Morgan
  • Drew Provan
  • Waleed Ghanima
  • Donald M Arnold
  • Yoshiaki Tomiyama
  • Cristina Santoro
  • Marc Michel
  • Serge Laborde
  • Barbara Lovrencic
  • Ming Hou
  • Tom Bailey
  • Gavin Taylor-Stokes
  • Jens Haenig
  • James B Bussel
View graph of relations

Immune thrombocytopenia (ITP) has a substantial, multifaceted impact on patients' health-related quality of life (HRQoL). Data describing which aspects of ITP physicians and patients perceive as having the greatest impact are limited. The ITP World Impact Survey (I-WISh) was a cross-sectional survey, including 1507 patients and 472 physicians, to establish the impact of ITP on HRQoL and productivity from patient and physician perspectives. Patients reported that ITP reduced their energy levels (85% of patients), capacity to exercise (77%), and limited their ability to perform daily tasks (75%). Eighty percent of physicians reported that ITP symptoms reduced patient HRQoL, with 66% reporting ITP-related fatigue substantially reduced patient HRQoL. Patients believed ITP had a substantial impact on emotional well-being (49%) and 63% worried their condition would worsen. Because of ITP, 49% of patients had already reduced, or seriously considered reducing their working hours, and 29% had considered terminating their employment. Thirty-six percent of patients employed at the time of the survey felt ITP decreased their work productivity, while 51% of patients with high/very high symptom burden reported that ITP affected their productivity. Note, I-WISh demonstrated substantive impact of ITP on patients' HRQoL both directly for patients and from the viewpoint of their physicians. Patients reported reduced energy levels, expressed fears their condition might worsen, and those who worked experienced reduced productivity. Physicians should be aware not only of platelet counts and bleeding but also the multi-dimensional impact of ITP on patients' lives as an integral component of disease management.

Original languageEnglish
JournalAmerican Journal of Hematology
Volume96
Issue number2
Pages (from-to)199-207
Number of pages9
ISSN0361-8609
DOIs
Publication statusPublished - 1 Feb 2021

Bibliographical note

© 2020 The Authors. American Journal of Hematology published by Wiley Periodicals LLC.

ID: 61127364